436
Views
3
CrossRef citations to date
0
Altmetric
Commentary

Arsenic in leukemia

A RSKy business

Pages 871-872 | Received 14 Aug 2013, Accepted 15 Aug 2013, Published online: 15 Aug 2013

References

  • Chou WC, Dang CV. Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Curr Opin Hematol 2005; 12:1 - 6; http://dx.doi.org/10.1097/01.moh.0000148552.93303.45; PMID: 15604884
  • Park MA, Hamed HA, Mitchell C, Cruickshanks N, Dash R, Allegood J, Dmitriev IP, Tye G, Ogretmen B, Spiegel S, et al. A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels. Mol Pharmacol 2011; 79:368 - 80; http://dx.doi.org/10.1124/mol.110.069484; PMID: 21119025
  • Galvin JP, Altman JK, Szilard A, Goussetis DJ, Vakana E, Sassano A, Platanias LC. Regulation of the kinase RSK1 by arsenic trioxide and generation of antileukemic responses. Cancer Biol Ther 2013; 14:411 - 6; http://dx.doi.org/10.4161/cbt.23760; PMID: 23377826
  • Lunghi P, Tabilio A, Lo-Coco F, Pelicci PG, Bonati A. Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells. Leukemia 2005; 19:234 - 44; http://dx.doi.org/10.1038/sj.leu.2403585; PMID: 15538402
  • McKinstry R, Qiao L, Yacoub A, Dai Y, Decker R, Holt S, Hagan MP, Grant S, Dent P. Inhibitors of MEK1/2 interact with UCN-01 to induce apoptosis and reduce colony formation in mammary and prostate carcinoma cells. Cancer Biol Ther 2002; 1:243 - 53; PMID: 12432271
  • Qiao L, Yacoub A, McKinstry R, Park JS, Caron R, Fisher PB, Hagan MP, Grant S, Dent P. Pharmocologic inhibitors of the mitogen activated protein kinase cascade have the potential to interact with ionizing radiation exposure to induce cell death in carcinoma cells by multiple mechanisms. Cancer Biol Ther 2002; 1:168 - 76; PMID: 12170777
  • Yacoub A, Han SI, Caron R, Gilfor D, Mooberry S, Grant S, Dent P. Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitro. Cancer Biol Ther 2003; 2:670 - 6; http://dx.doi.org/10.4161/cbt.2.6.534; PMID: 14688474
  • Qiao L, Yu J, Dent P, Farrell G. NF-kappaB protects rat ARL-6 hepatocellular carcinoma cells against hydrogen peroxide-induced apoptosis. Cancer Biol Ther 2005; 4:1195 - 202; http://dx.doi.org/10.4161/cbt.4.11.2078; PMID: 16177566
  • Zhang Y, Zhong S, Dong Z, Chen N, Bode AM, Ma W, Dong Z. UVA induces Ser381 phosphorylation of p90RSK/MAPKAP-K1 via ERK and JNK pathways. J Biol Chem 2001; 276:14572 - 80; http://dx.doi.org/10.1074/jbc.M004615200; PMID: 11278279